Xeris Pharmaceuticals (XERS) went public on June 21, 2018, when it opened at a split-adjusted price of $15.75.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
March 2025 | $3.85 | $4.68 | $3.59 | $4.39 | 31,198,893 |
February 2025 | $3.48 | $4.10 | $3.45 | $3.83 | 34,303,000 |
January 2025 | $3.39 | $3.78 | $3.14 | $3.56 | 30,360,400 |
December 2024 | $3.29 | $3.87 | $3.17 | $3.39 | 34,426,300 |
November 2024 | $3.26 | $3.64 | $2.82 | $3.28 | 37,906,200 |
October 2024 | $2.85 | $3.39 | $2.69 | $3.22 | 27,707,853 |
September 2024 | $2.79 | $3.04 | $2.48 | $2.85 | 36,437,750 |
August 2024 | $2.49 | $2.94 | $2.10 | $2.81 | 35,378,712 |
July 2024 | $2.24 | $2.67 | $2.03 | $2.48 | 25,512,492 |
June 2024 | $2.29 | $2.51 | $2.07 | $2.25 | 26,483,073 |
May 2024 | $1.74 | $2.41 | $1.72 | $2.26 | 32,680,369 |
April 2024 | $2.26 | $2.26 | $1.69 | $1.75 | 28,132,020 |
March 2024 | $3.13 | $3.26 | $2.00 | $2.21 | 48,448,895 |
February 2024 | $2.50 | $3.26 | $2.39 | $3.08 | 39,634,119 |
January 2024 | $2.31 | $3.02 | $2.18 | $2.46 | 56,884,835 |
December 2023 | $1.84 | $2.44 | $1.78 | $2.35 | 30,764,837 |
November 2023 | $1.85 | $2.18 | $1.46 | $1.86 | 35,538,650 |
October 2023 | $1.84 | $1.95 | $1.55 | $1.83 | 18,407,661 |
September 2023 | $2.30 | $2.47 | $1.73 | $1.86 | 19,755,673 |
August 2023 | $2.63 | $2.78 | $2.08 | $2.27 | 21,379,124 |
July 2023 | $2.60 | $2.75 | $2.30 | $2.61 | 18,222,527 |
June 2023 | $2.56 | $3.07 | $2.30 | $2.62 | 28,464,656 |
May 2023 | $2.25 | $3.03 | $2.20 | $2.56 | 30,045,585 |
April 2023 | $1.64 | $2.42 | $1.64 | $2.26 | 27,207,464 |
March 2023 | $1.36 | $1.70 | $1.13 | $1.63 | 27,150,162 |
